Both sides appeared to be holding hard lines and digging in following the landslide reelection of President Barack Obama, but during the first talks Friday each side showed more of a willingness to compromise.
Those of us in the press followed, digginghard for stories about corporate malfeasance and regulators asleep at the switch. (There was plenty to find.) Suddenly, being an FDA reviewer who had been too easy on a new drug meant that you might have to defend yourself in front of Congress.